View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . March 9th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Alnylam Pharmaceuticals, Inc. - Alnylam Pharmaceuticals Reports Fourth Quarter and 2008 Financial Results

Uveitis - ESBATech's Antibody Fragment ESBA105 Enters Phase IIa in Uveitis Study

Winston Pharmaceuticals, Inc. - Winston Pharmaceuticals, Inc. Receives Orphan Drug Designation for Novel Patch to Treat Post-Herpetic Neuralgia

Breast Cancer - Recent studies from University of British Columbia add new data to breast cancer

Breast Cancer - Study findings from R. Maisano et al provide new insights into breast cancer

Cancer Vaccines - New findings from University of California in the area of cancer vaccines described

Clinical Trial Research - Research reports on clinical trial research from Harvard University, Medical Department provide new insights

Enzyme Research - Researchers from Leiden University report recent findings in enzyme research

Erectile Dysfunction - Research from S. Glina and co-researchers provides new data on erectile dysfunction

Gastric Cancer - Data on gastric cancer discussed by R.B. Lin and colleagues

HIV/AIDS - Reports outline HIV/AIDS research from University of California

Immunotherapy - New immunotherapy study findings recently were reported by researchers at University of Bristol

Ischemia - Findings from University of Texas, Medical Department broaden understanding of ischemia

Life Sciences - New life sciences findings from M.S. Joy and co-authors described

Life Sciences - New research on life sciences from Northwestern University summarized

Life Sciences - Vrije University Amsterdam details research in life sciences

Monoclonal Antibodies - Findings from D.P. Toth and co-researchers advance knowledge in monoclonal antibodies

Non-Small Cell Lung Cancer - Findings from N. Yamamoto and co-authors broaden understanding of non-small cell lung cancer

Pancreatic Cancer - Studies from H. Riess and co-researchers in the area of pancreatic cancer published

Penile Induration - New penile induration findings from P. Gontero and co-researchers published

T-Cell Lymphoma - Researchers from Seoul National University, Medical Department publish findings in t-cell lymphoma

Alzheimer Disease Therapy - Findings in Alzheimer disease therapy reported from Research Center

Colon Cancer Therapy - Reports on colon cancer therapy findings from Kaplan Medical Center provide new insights

Hepatitis C Virus Vaccines - New research on hepatitis C virus vaccines from L. Alvarez-Lajonchere and co-authors summarized

Life Sciences - Reports summarize life sciences research from AstraZeneca

Mantle Cell Lymphoma Therapy - New mantle cell lymphoma therapy study findings have been reported from Derriford Hospital, Department of Haematology

Myeloma Therapy - Studies from Peter MacCallum Cancer Center yield new information about myeloma therapy

Myeloma Therapy - Studies from University Hospital in the area of myeloma therapy described

Non-Small Cell Lung Cancer Therapy - New non-small cell lung cancer therapy research has been reported by J. Trédaniel et al

Pharmacokinetics - Studies from Y. Zhu and co-authors have provided new information about pharmacokinetics

Acorda Therapeutics, Inc. - Acorda Therapeutics Reports Fourth Quarter and Full Year 2008 Financial Results

Adolor Corporation - Adolor Corporation Reports Year-End 2008 Financial Results

Alexion Pharmaceuticals, Inc. - Alexion’s Soliris eculizumab Receives Marketing Approval in Australia for All Patients with PNH

Alzheimer Disease - ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease

Amicus Therapeutics - Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease

Asthma - AstraZeneca's Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints

Asthma - MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints

AVEO Pharmaceuticals, Inc. - AVEO Pharmaceuticals’ Oral, Triple VEGF Receptor Inhibitor AV-951 Shows Robust Activity in Patients with Advanced Kidney Cancer

Cancer Vaccines - Bavarian Nordic Updates on Phase I/II Studies With Breast Cancer Vaccine

Cancer Vaccines - BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine

CardioVascular BioTherapeutics, Inc. - CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial

Clinical Trial Research - Rigel Announces Fourth Quarter and Year End 2008 Financial Results

CPEX Pharmaceuticals, Inc. - CPEX Pharmaceuticals Announces Completion of Phase 2 Trial for Urology Drug by Serenity Pharmaceuticals

CPEX Pharmaceuticals, Inc. - CPEX Pharmaceuticals Initiates Phase II Clinical Trial of Nasulin®

Elan Corporation, plc - Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process

Genzyme Corp. - Study of Genzyme Oral Compound for Gaucher Disease Meets Primary Endpoint

GTx, Inc. - GTx Initiates Phase I Clinical Trial for GTx-758, an Oral Luteinizing Hormone Inhibitor for Advanced Prostate Cancer

Hawaii Biotech, Inc. - Hawaii Biotech Reports Phase 1 Results for West Nile Virus Vaccine

Influenza - Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections

Knee Replacement - QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy

Knoll, Inc. - Knoll Reduces Greenhouse Gas Emissions by 10.4%, Two Years Ahead of Schedule; Credits Chicago Climate Exchange for Structure, Education that Contributed to Success

MannKind Corporation - MannKind Updates Status of NDA Submission for AFRESA

Myeloma - Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO

Optimer Pharmaceuticals, Inc. - Optimer Pharmaceuticals Announces Positive Results from Second Phase 3 Study of Prulifloxacin for Infectious Diarrhea in Travelers

Oxygen Biotherapeutics, Inc. - Oxygen Biotherapeutics, Inc. Hires Contract Research Organization and Identifies Swiss Trial Sites for Additional Oxycyte® Phase II Clinical Trials

Pfizer Inc - Pfizer Discontinues Development of Two Phase 3 Compounds

Prostate Cancer - Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

Prostate Cancer - Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer

Seattle Genetics, Inc. - Seattle Genetics Completes Enrollment in Lintuzumab Phase IIb Clinical Trial for Patients with Acute Myeloid Leukemia

Ulcerative Colitis - ActoGeniX completes equity financing round of EUR 13.5 million

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx